PubMed · 17073758
Cannabinoids and PPARalpha signalling.
Abstract
Cannabinoids have been shown to possess anti-inflammatory and neuroprotective properties, which were proposed to occur mainly via activation of the G-protein-coupled receptor CB(1) (cannabinoid receptor 1). Recently, certain cannabinoids have been reported to be ligands for members of the nuclear receptor transcription factor superfamily known as PPARs (peroxisome-proliferator-activated receptors). This review summarizes the evidence for cannabinoid activation of PPARs and identifies a new intracellular target for cannabinoids as therapeutic agents for neuroprotective treatment.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Y Sun, S P H Alexander, D A Kendall, A J Bennett. 2006. Cannabinoids and PPARalpha signalling.. https://doi.org/10.1042/bst0341095
Cite the original work for its findings. Save a collection to share your selection of sources.